Private Equity Investment in Clinical Trial Sites Raises Potential Antitrust, CPOM Concerns
Private equity’s growing interest in clinical trial sites and services raises questions about how increased consolidation will impact the cost and sustainability of pharmaceutical research and...
Apr 17, 2026
Read Now >

